BPCGY vs ALNY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BPCGY · BANCO COMERCIAL PORTUGUES S.A. UNSP ADR EACH REPR 10 ORD SHS(POST SPLT)$12.11 ▼ 1.20%
ALNY · Alnylam Pharmaceuticals$155.94 ▼ 0.46%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BPCGY +41.8%
- ALNY -64.7%
Head to head
| Metric | BPCGY | ALNY |
|---|---|---|
| Price | $12.11 | $155.94 |
| Change today | ▼ 1.20% | ▼ 0.46% |
| Market cap | $20.83B | $20.89B |
| Return, 3 months | -7.6% | -28.1% |
| Return, year to date | +17.3% | -60.8% |
| Return, 1 year | +41.8% | -64.8% |
| P/E (TTM) | 18.6 | 8.1 |
| P/B | 2.1 | 5.8 |
| P/E percentile vs own 5y | – | 80th |
| Dividend yield | 3.28% | – |
| Revenue growth (YoY, latest qtr) | – | +16.7% |
| Net profit growth (YoY) | – | +640.5% |
| Gross margin | – | 77.3% |
| Operating margin | – | 19.5% |
| Net margin | – | 52.8% |
| Return on equity | – | 138.1% |
| Analyst target vs. price | – | +103.5% |
| Analyst buy share | – | 76% |
| RSI (14) | 44 | 22 |
| 30-day volatility | 76.4% | 90.9% |
| Max drawdown, 1 year | -24.1% | -67.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ALNY is the largest of the group by market value.
- BPCGY has returned the most over the past year.
- ALNY carries the lowest trailing P/E.
- BPCGY has been the calmest stock over the last 30 days.